Jonathan Wolleben's Stock Ratings

Citizens Capital Markets Analyst

Jonathan Wolleben is an analyst at Citizens Capital Markets. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/19/2025

Overall Average Return

10.2%

Smart Score

66.9%

Overall Average Return Percentile

64th

Number of Ratings

198
Buy NowGet Alert
03/14/2025ALTBuy Now
Altimmune
$5.56349.64%
Jonathan Wolleben66%
$25 → $25ReiteratesMarket Outperform → Market OutperformGet Alert
03/10/2025PTGXBuy Now
Protagonist Therapeutics
$53.3014.45%
Jonathan Wolleben66%
$61 → $61ReiteratesMarket Outperform → Market OutperformGet Alert
03/04/2025OCULBuy Now
Ocular Therapeutix
$7.45155.03%
Jonathan Wolleben66%
$22 → $19MaintainsMarket OutperformGet Alert
03/04/2025DBVTBuy Now
DBV Technologies
$5.0199.6%
Jonathan Wolleben66%
$10 → $10ReiteratesMarket Outperform → Market OutperformGet Alert
03/03/2025PHVSBuy Now
Pharvaris
$15.96244.61%
Jonathan Wolleben66%
$55 → $55ReiteratesMarket Outperform → Market OutperformGet Alert
03/03/2025KALVBuy Now
KalVista Pharma
$12.4752.37%
Jonathan Wolleben66%
$19 → $19ReiteratesMarket Outperform → Market OutperformGet Alert
03/03/2025BCRXBuy Now
BioCryst Pharma
$7.55138.41%
Jonathan Wolleben66%
$18 → $18ReiteratesMarket Outperform → Market OutperformGet Alert
03/03/2025ATXSBuy Now
Astria Therapeutics
$6.49300.62%
Jonathan Wolleben66%
$26 → $26ReiteratesMarket Outperform → Market OutperformGet Alert
02/28/2025GPCRBuy Now
Structure Therapeutics
$21.62302.41%
Jonathan Wolleben66%
$91 → $87MaintainsMarket OutperformGet Alert
02/28/2025CRNXBuy Now
Crinetics Pharmaceuticals
$34.18166.24%
Jonathan Wolleben66%
$92 → $91MaintainsMarket OutperformGet Alert
02/25/2025BCRXBuy Now
BioCryst Pharma
$7.55138.41%
Jonathan Wolleben66%
$18 → $18ReiteratesMarket Outperform → Market OutperformGet Alert
02/24/2025MIRMBuy Now
Mirum Pharmaceuticals
$44.0068.18%
Jonathan Wolleben66%
$74 → $74ReiteratesMarket Outperform → Market OutperformGet Alert
02/07/2025PTGXBuy Now
Protagonist Therapeutics
$53.308.82%
Jonathan Wolleben66%
$58 → $58ReiteratesMarket Outperform → Market OutperformGet Alert
01/31/2025PHVSBuy Now
Pharvaris
$15.96244.61%
Jonathan Wolleben66%
$46 → $55MaintainsMarket OutperformGet Alert
01/31/2025KALVBuy Now
KalVista Pharma
$12.4752.37%
Jonathan Wolleben66%
→ $19Initiates → Market OutperformGet Alert
01/31/2025BCRXBuy Now
BioCryst Pharma
$7.55138.41%
Jonathan Wolleben66%
$18 → $18ReiteratesMarket Outperform → Market OutperformGet Alert
01/31/2025ATXSBuy Now
Astria Therapeutics
$6.49300.62%
Jonathan Wolleben66%
→ $26Initiates → Market OutperformGet Alert
01/10/2025MDGLBuy Now
Madrigal Pharmaceuticals
$340.5025.4%
Jonathan Wolleben66%
$427 → $427ReiteratesMarket Outperform → Market OutperformGet Alert
01/10/2025DBVTBuy Now
DBV Technologies
$5.0199.6%
Jonathan Wolleben66%
$10 → $10ReiteratesMarket Outperform → Market OutperformGet Alert
12/23/2024RYTMBuy Now
Rhythm Pharmaceuticals
$52.2943.43%
Jonathan Wolleben66%
$75 → $75ReiteratesMarket Outperform → Market OutperformGet Alert
12/19/2024SVRABuy Now
Savara
$2.61244.83%
Jonathan Wolleben66%
$9 → $9ReiteratesMarket Outperform → Market OutperformGet Alert
12/18/2024HGVBuy Now
Hilton Grand Vacations
$36.2338.01%
Jonathan Wolleben66%
$55 → $50MaintainsMarket OutperformGet Alert
12/18/2024GPCRBuy Now
Structure Therapeutics
$21.62320.91%
Jonathan Wolleben66%
$91 → $91ReiteratesMarket Outperform → Market OutperformGet Alert
12/16/2024CSGPBuy Now
CoStar Gr
$78.9613.98%
Jonathan Wolleben66%
$90 → $90ReiteratesMarket Outperform → Market OutperformGet Alert
12/16/2024CRNXBuy Now
Crinetics Pharmaceuticals
$34.18154.53%
Jonathan Wolleben66%
$87 → $87ReiteratesMarket Outperform → Market OutperformGet Alert
12/16/2024ABNBBuy Now
Airbnb
$124.17
Jonathan Wolleben66%
ReiteratesMarket Perform → Market PerformGet Alert
12/12/2024PRQRBuy Now
ProQR Therapeutics
$1.71367.84%
Jonathan Wolleben66%
$8 → $8ReiteratesMarket Outperform → Market OutperformGet Alert
12/11/2024SPRBBuy Now
Spruce Biosciences
$0.32846.37%
Jonathan Wolleben66%
$3 → $3DowngradeMarket Outperform → Market PerformGet Alert
12/10/2024DBVTBuy Now
DBV Technologies
$5.0199.6%
Jonathan Wolleben66%
$10 → $10ReiteratesMarket Outperform → Market OutperformGet Alert
11/13/2024SPOTBuy Now
Spotify Technology
$571.36-15.11%
Jonathan Wolleben66%
$420 → $485DowngradeBuy → AccumulateGet Alert
10/01/2024SVRABuy Now
Savara
$2.61244.83%
Jonathan Wolleben66%
$9 → $9ReiteratesMarket Outperform → Market OutperformGet Alert
09/27/2024CRNXBuy Now
Crinetics Pharmaceuticals
$34.18134.06%
Jonathan Wolleben66%
$80 → $80ReiteratesMarket Outperform → Market OutperformGet Alert
09/26/2024ALLKBuy Now
Allakos
$0.251080.17%
Jonathan Wolleben66%
$3 → $3ReiteratesMarket Outperform → Market OutperformGet Alert
09/24/2024DBVTBuy Now
DBV Technologies
$5.01-0.2%
Jonathan Wolleben66%
$25 → $25ReiteratesMarket Outperform → Market OutperformGet Alert
09/17/2024RYTMBuy Now
Rhythm Pharmaceuticals
$52.2922.39%
Jonathan Wolleben66%
→ $64Initiates → Market OutperformGet Alert
09/13/2024AURABuy Now
Aura Biosciences
$7.42209.97%
Jonathan Wolleben66%
$19 → $23MaintainsMarket OutperformGet Alert
09/10/2024SKYEBuy Now
Skye Bioscience
$2.37532.91%
Jonathan Wolleben66%
→ $15Initiates → Market OutperformGet Alert
09/09/2024SVRABuy Now
Savara
$2.61244.83%
Jonathan Wolleben66%
$9 → $9ReiteratesMarket Outperform → Market OutperformGet Alert
08/28/2024AURABuy Now
Aura Biosciences
$7.42156.06%
Jonathan Wolleben66%
$19 → $19ReiteratesMarket Outperform → Market OutperformGet Alert
08/15/2024SGMTBuy Now
Sagimet Biosciences
$3.85731.17%
Jonathan Wolleben66%
$48 → $32MaintainsMarket OutperformGet Alert
08/13/2024SVRABuy Now
Savara
$2.61244.83%
Jonathan Wolleben66%
$10 → $9MaintainsMarket OutperformGet Alert
08/09/2024GPCRBuy Now
Structure Therapeutics
$21.62297.78%
Jonathan Wolleben66%
$91 → $86MaintainsMarket OutperformGet Alert
08/07/2024PTGXBuy Now
Protagonist Therapeutics
$53.30-19.32%
Jonathan Wolleben66%
$45 → $43MaintainsMarket OutperformGet Alert
08/06/2024BCRXBuy Now
BioCryst Pharma
$7.55111.92%
Jonathan Wolleben66%
$15 → $16MaintainsMarket OutperformGet Alert
07/31/2024DBVTBuy Now
DBV Technologies
$5.01-0.2%
Jonathan Wolleben66%
$20 → $25MaintainsMarket OutperformGet Alert
07/16/2024MDGLBuy Now
Madrigal Pharmaceuticals
$340.5013.07%
Jonathan Wolleben66%
$381 → $385MaintainsMarket OutperformGet Alert
06/26/2024ALLKBuy Now
Allakos
$0.251080.17%
Jonathan Wolleben66%
$3 → $3ReiteratesMarket Outperform → Market OutperformGet Alert
06/18/2024MIRMBuy Now
Mirum Pharmaceuticals
$44.0054.55%
Jonathan Wolleben66%
$66 → $68MaintainsMarket OutperformGet Alert
06/17/2024PTGXBuy Now
Protagonist Therapeutics
$53.30-15.57%
Jonathan Wolleben66%
$45 → $45ReiteratesMarket Outperform → Market OutperformGet Alert
06/07/2024SGMTBuy Now
Sagimet Biosciences
$3.851146.75%
Jonathan Wolleben66%
$48 → $48ReiteratesMarket Outperform → Market OutperformGet Alert
06/04/2024CRNXBuy Now
Crinetics Pharmaceuticals
$34.18134.06%
Jonathan Wolleben66%
$80 → $80ReiteratesMarket Outperform → Market OutperformGet Alert
05/31/2024LRMRBuy Now
Larimar Therapeutics
$2.39946.03%
Jonathan Wolleben66%
$25 → $25ReiteratesMarket Outperform → Market OutperformGet Alert
05/24/2024SGMTBuy Now
Sagimet Biosciences
$3.851146.75%
Jonathan Wolleben66%
$48 → $48ReiteratesMarket Outperform → Market OutperformGet Alert
05/21/2024LRMRBuy Now
Larimar Therapeutics
$2.39946.03%
Jonathan Wolleben66%
$25 → $25ReiteratesMarket Outperform → Market OutperformGet Alert
05/10/2024GPCRBuy Now
Structure Therapeutics
$21.62320.91%
Jonathan Wolleben66%
$91 → $91ReiteratesMarket Outperform → Market OutperformGet Alert
05/10/2024CRNXBuy Now
Crinetics Pharmaceuticals
$34.18134.06%
Jonathan Wolleben66%
$80 → $80ReiteratesMarket Outperform → Market OutperformGet Alert
05/10/2024ALTBuy Now
Altimmune
$5.56331.65%
Jonathan Wolleben66%
$25 → $24MaintainsMarket OutperformGet Alert
05/09/2024MIRMBuy Now
Mirum Pharmaceuticals
$44.0050%
Jonathan Wolleben66%
$72 → $66MaintainsMarket OutperformGet Alert
05/08/2024PTGXBuy Now
Protagonist Therapeutics
$53.30-15.57%
Jonathan Wolleben66%
$42 → $45MaintainsMarket OutperformGet Alert
05/08/2024OCULBuy Now
Ocular Therapeutix
$7.45195.3%
Jonathan Wolleben66%
$24 → $22MaintainsMarket OutperformGet Alert
05/08/2024MDGLBuy Now
Madrigal Pharmaceuticals
$340.5011.89%
Jonathan Wolleben66%
$397 → $381MaintainsMarket OutperformGet Alert
05/07/2024BCRXBuy Now
BioCryst Pharma
$7.5598.68%
Jonathan Wolleben66%
$14 → $15MaintainsMarket OutperformGet Alert
05/06/2024SVRABuy Now
Savara
$2.61206.51%
Jonathan Wolleben66%
$8 → $8ReiteratesMarket Outperform → Market OutperformGet Alert
04/19/2024SVRABuy Now
Savara
$2.61206.51%
Jonathan Wolleben66%
$8 → $8ReiteratesMarket Outperform → Market OutperformGet Alert
04/19/2024RLYBBuy Now
Rallybio
$0.74980.64%
Jonathan Wolleben66%
$8 → $8ReiteratesMarket Outperform → Market OutperformGet Alert
04/18/2024SVRABuy Now
Savara
$2.61206.51%
Jonathan Wolleben66%
$8 → $8ReiteratesMarket Outperform → Market OutperformGet Alert
04/18/2024RLYBBuy Now
Rallybio
$0.74980.64%
Jonathan Wolleben66%
$8 → $8ReiteratesMarket Outperform → Market OutperformGet Alert
04/16/2024OCULBuy Now
Ocular Therapeutix
$7.45222.15%
Jonathan Wolleben66%
$24 → $24ReiteratesMarket Outperform → Market OutperformGet Alert
04/11/2024PHVSBuy Now
Pharvaris
$15.96213.28%
Jonathan Wolleben66%
$49 → $50MaintainsMarket OutperformGet Alert
03/28/2024CRNXBuy Now
Crinetics Pharmaceuticals
$34.18134.06%
Jonathan Wolleben66%
$80 → $80ReiteratesMarket Outperform → Market OutperformGet Alert
03/20/2024CRNXBuy Now
Crinetics Pharmaceuticals
$34.18134.06%
Jonathan Wolleben66%
$60 → $80MaintainsMarket OutperformGet Alert
03/15/2024LRMRBuy Now
Larimar Therapeutics
$2.39946.03%
Jonathan Wolleben66%
$25 → $25ReiteratesMarket Outperform → Market OutperformGet Alert
03/15/2024MDGLBuy Now
Madrigal Pharmaceuticals
$340.5016.59%
Jonathan Wolleben66%
$351 → $397MaintainsOutperformGet Alert
03/14/2024SPRBBuy Now
Spruce Biosciences
$0.32846.37%
Jonathan Wolleben66%
$8 → $3MaintainsMarket OutperformGet Alert
03/14/2024MIRMBuy Now
Mirum Pharmaceuticals
$44.0063.64%
Jonathan Wolleben66%
$69 → $72MaintainsOutperformGet Alert
03/13/2024RLYBBuy Now
Rallybio
$0.74980.64%
Jonathan Wolleben66%
$8 → $8ReiteratesMarket Outperform → Market OutperformGet Alert
03/13/2024OCULBuy Now
Ocular Therapeutix
$7.45222.15%
Jonathan Wolleben66%
$24 → $24ReiteratesMarket Outperform → Market OutperformGet Alert
03/13/2024CLSDBuy Now
Clearside Biomedical
$0.95426.09%
Jonathan Wolleben66%
$5 → $5ReiteratesMarket Outperform → Market OutperformGet Alert
03/12/2024LRMRBuy Now
Larimar Therapeutics
$2.39946.03%
Jonathan Wolleben66%
$25 → $25ReiteratesMarket Outperform → Market OutperformGet Alert
03/12/2024OCULBuy Now
Ocular Therapeutix
$7.45222.15%
Jonathan Wolleben66%
$12 → $24MaintainsMarket OutperformGet Alert
03/11/2024PTGXBuy Now
Protagonist Therapeutics
$53.30-21.2%
Jonathan Wolleben66%
$42 → $42ReiteratesMarket Outperform → Market OutperformGet Alert
03/08/2024GPCRBuy Now
Structure Therapeutics
$21.62320.91%
Jonathan Wolleben66%
$91 → $91ReiteratesMarket Outperform → Market OutperformGet Alert
02/29/2024MIRMBuy Now
Mirum Pharmaceuticals
$44.0056.82%
Jonathan Wolleben66%
$64 → $69MaintainsMarket OutperformGet Alert
02/29/2024CRNXBuy Now
Crinetics Pharmaceuticals
$34.1875.54%
Jonathan Wolleben66%
$50 → $60MaintainsMarket OutperformGet Alert
02/23/2024MDGLBuy Now
Madrigal Pharmaceuticals
$340.501.91%
Jonathan Wolleben66%
$347 → $347ReiteratesMarket Outperform → Market OutperformGet Alert
02/16/2024MDGLBuy Now
Madrigal Pharmaceuticals
$340.501.91%
Jonathan Wolleben66%
$347 → $347ReiteratesMarket Outperform → Market OutperformGet Alert
02/15/2024SVRABuy Now
Savara
$2.61206.51%
Jonathan Wolleben66%
→ $8Initiates → Market OutperformGet Alert
02/14/2024PHVSBuy Now
Pharvaris
$15.96207.02%
Jonathan Wolleben66%
$49 → $49ReiteratesMarket Outperform → Market OutperformGet Alert
02/13/2024LRMRBuy Now
Larimar Therapeutics
$2.39946.03%
Jonathan Wolleben66%
$17 → $25MaintainsMarket OutperformGet Alert
02/07/2024SGMTBuy Now
Sagimet Biosciences
$3.851094.81%
Jonathan Wolleben66%
$47 → $46MaintainsMarket OutperformGet Alert
02/07/2024RLYBBuy Now
Rallybio
$0.74980.64%
Jonathan Wolleben66%
$16 → $8MaintainsMarket OutperformGet Alert
01/23/2024PHVSBuy Now
Pharvaris
$15.96207.02%
Jonathan Wolleben66%
$40 → $49MaintainsMarket OutperformGet Alert
01/23/2024SGMTBuy Now
Sagimet Biosciences
$3.851120.78%
Jonathan Wolleben66%
$31 → $47MaintainsMarket OutperformGet Alert
01/22/2024SGMTBuy Now
Sagimet Biosciences
$3.851120.78%
Jonathan Wolleben66%
$31 → $47MaintainsMarket OutperformGet Alert
01/17/2024ALLKBuy Now
Allakos
$0.251080.17%
Jonathan Wolleben66%
$10 → $3MaintainsMarket OutperformGet Alert
01/11/2024MIRMBuy Now
Mirum Pharmaceuticals
$44.0045.45%
Jonathan Wolleben66%
$64 → $64ReiteratesMarket Outperform → Market OutperformGet Alert
12/05/2023SGMTBuy Now
Sagimet Biosciences
$3.85705.19%
Jonathan Wolleben66%
→ $31ReiteratesMarket Outperform → Market OutperformGet Alert
11/28/2023ALLKBuy Now
Allakos
$0.253833.91%
Jonathan Wolleben66%
→ $10ReiteratesMarket Outperform → Market OutperformGet Alert
11/20/2023GPCRBuy Now
Structure Therapeutics
$21.62320.91%
Jonathan Wolleben66%
→ $91ReiteratesMarket Outperform → Market OutperformGet Alert
11/15/2023GPCRBuy Now
Structure Therapeutics
$21.62320.91%
Jonathan Wolleben66%
$90 → $91MaintainsMarket OutperformGet Alert
11/14/2023MDGLBuy Now
Madrigal Pharmaceuticals
$340.5012.48%
Jonathan Wolleben66%
→ $383ReiteratesMarket Outperform → Market OutperformGet Alert
11/14/2023ALLKBuy Now
Allakos
$0.253833.91%
Jonathan Wolleben66%
$11 → $10MaintainsMarket OutperformGet Alert
11/10/2023AURABuy Now
Aura Biosciences
$7.42156.06%
Jonathan Wolleben66%
$21 → $19MaintainsMarket OutperformGet Alert
11/03/2023PTGXBuy Now
Protagonist Therapeutics
$53.30-30.58%
Jonathan Wolleben66%
$35 → $37MaintainsMarket OutperformGet Alert
10/19/2023GPCRBuy Now
Structure Therapeutics
$21.62316.28%
Jonathan Wolleben66%
→ $90Initiates → Market OutperformGet Alert
10/18/2023MIRMBuy Now
Mirum Pharmaceuticals
$44.0059.09%
Jonathan Wolleben66%
→ $70ReiteratesMarket Outperform → Market OutperformGet Alert
10/09/2023MIRMBuy Now
Mirum Pharmaceuticals
$44.0059.09%
Jonathan Wolleben66%
→ $70ReiteratesMarket Outperform → Market OutperformGet Alert
09/27/2023ALLKBuy Now
Allakos
$0.254227.3%
Jonathan Wolleben66%
→ $11Initiates → Market OutperformGet Alert
09/20/2023MIRMBuy Now
Mirum Pharmaceuticals
$44.0059.09%
Jonathan Wolleben66%
→ $70Initiates → Market OutperformGet Alert
09/05/2023RLYBBuy Now
Rallybio
$0.742061.29%
Jonathan Wolleben66%
→ $16ReiteratesMarket Outperform → Market OutperformGet Alert
08/16/2023SPRBBuy Now
Spruce Biosciences
$0.322423.66%
Jonathan Wolleben66%
$7 → $8MaintainsOutperformGet Alert
08/15/2023LRMRBuy Now
Larimar Therapeutics
$2.39611.3%
Jonathan Wolleben66%
→ $17ReiteratesMarket Outperform → Market OutperformGet Alert
08/15/2023CLSDBuy Now
Clearside Biomedical
$0.95426.09%
Jonathan Wolleben66%
→ $5ReiteratesMarket Outperform → Market OutperformGet Alert
08/09/2023CRNXBuy Now
Crinetics Pharmaceuticals
$34.1822.88%
Jonathan Wolleben66%
$43 → $42MaintainsMarket OutperformGet Alert
08/08/2023SGMTBuy Now
Sagimet Biosciences
$3.85679.22%
Jonathan Wolleben66%
→ $30Initiates → Market OutperformGet Alert
08/01/2023DBVTBuy Now
DBV Technologies
$5.01-20.16%
Jonathan Wolleben66%
→ $40ReiteratesMarket Outperform → Market OutperformGet Alert
07/25/2023RLYBBuy Now
Rallybio
$0.742061.29%
Jonathan Wolleben66%
→ $16ReiteratesMarket Outperform → Market OutperformGet Alert
07/12/2023CLSDBuy Now
Clearside Biomedical
$0.95426.09%
Jonathan Wolleben66%
→ $5ReiteratesMarket Outperform → Market OutperformGet Alert
07/12/2023ALTBuy Now
Altimmune
$5.56169.78%
Jonathan Wolleben66%
→ $15ReiteratesMarket Outperform → Market OutperformGet Alert
07/06/2023PTGXBuy Now
Protagonist Therapeutics
$53.30-34.33%
Jonathan Wolleben66%
$28 → $35MaintainsMarket OutperformGet Alert
06/26/2023RLYBBuy Now
Rallybio
$0.742061.29%
Jonathan Wolleben66%
$26 → $16MaintainsMarket OutperformGet Alert
06/15/2023CRNXBuy Now
Crinetics Pharmaceuticals
$34.1825.8%
Jonathan Wolleben66%
→ $43ReiteratesMarket Outperform → Market OutperformGet Alert
06/13/2023OCULBuy Now
Ocular Therapeutix
$7.4561.07%
Jonathan Wolleben66%
→ $12Reiterates → Market OutperformGet Alert
05/17/2023PRQRBuy Now
ProQR Therapeutics
$1.71250.88%
Jonathan Wolleben66%
→ $6ReiteratesMarket Outperform → Market OutperformGet Alert
05/16/2023SPRBBuy Now
Spruce Biosciences
$0.322108.2%
Jonathan Wolleben66%
→ $7ReiteratesMarket Outperform → Market OutperformGet Alert
05/16/2023LRMRBuy Now
Larimar Therapeutics
$2.39527.62%
Jonathan Wolleben66%
→ $15ReiteratesMarket Outperform → Market OutperformGet Alert
05/12/2023WMGBuy Now
Warner Music Gr
$32.50-26.15%
Jonathan Wolleben66%
$25 → $24MaintainsOutperformGet Alert
05/11/2023DBVTBuy Now
DBV Technologies
$5.01-20.16%
Jonathan Wolleben66%
→ $40ReiteratesMarket Outperform → Market OutperformGet Alert
05/11/2023ALTBuy Now
Altimmune
$5.56169.78%
Jonathan Wolleben66%
$15 → $15ReinstatesMarket Outperform → Market OutperformGet Alert
05/09/2023OCULBuy Now
Ocular Therapeutix
$7.4561.07%
Jonathan Wolleben66%
$11 → $12MaintainsOutperformGet Alert
05/08/2023PHVSBuy Now
Pharvaris
$15.9625.31%
Jonathan Wolleben66%
→ $20Reiterates → Market OutperformGet Alert
05/05/2023DBVTBuy Now
DBV Technologies
$5.01-20.16%
Jonathan Wolleben66%
→ $40MaintainsMarket OutperformGet Alert
05/05/2023CRNXBuy Now
Crinetics Pharmaceuticals
$34.1825.8%
Jonathan Wolleben66%
$41 → $43MaintainsOutperformGet Alert
04/28/2023CLSDBuy Now
Clearside Biomedical
$0.95531.31%
Jonathan Wolleben66%
→ $6Reiterates → Market OutperformGet Alert
04/27/2023DBVTBuy Now
DBV Technologies
$5.01-20.16%
Jonathan Wolleben66%
→ $40Reiterates → Market OutperformGet Alert
04/06/2023PHVSBuy Now
Pharvaris
$15.9625.31%
Jonathan Wolleben66%
$23 → $20MaintainsMarket OutperformGet Alert
03/31/2023ALTBuy Now
Altimmune
$5.56169.78%
Jonathan Wolleben66%
→ $15Reiterates → Market OutperformGet Alert
03/30/2023PRQRBuy Now
ProQR Therapeutics
$1.71250.88%
Jonathan Wolleben66%
→ $6Reiterates → Market OutperformGet Alert
03/22/2023ALTBuy Now
Altimmune
$5.56367.63%
Jonathan Wolleben66%
→ $26Reiterates → Market OutperformGet Alert
03/17/2023SPRBBuy Now
Spruce Biosciences
$0.322108.2%
Jonathan Wolleben66%
→ $7MaintainsMarket OutperformGet Alert
03/16/2023PTGXBuy Now
Protagonist Therapeutics
$53.30-47.47%
Jonathan Wolleben66%
$31 → $28MaintainsMarket OutperformGet Alert
03/16/2023AURABuy Now
Aura Biosciences
$7.42236.93%
Jonathan Wolleben66%
$30 → $25MaintainsOutperformGet Alert
03/14/2023LRMRBuy Now
Larimar Therapeutics
$2.39527.62%
Jonathan Wolleben66%
$15 → $15MaintainsMarket OutperformGet Alert
03/10/2023CLSDBuy Now
Clearside Biomedical
$0.95531.31%
Jonathan Wolleben66%
$7 → $6MaintainsMarket OutperformGet Alert
03/08/2023PTGXBuy Now
Protagonist Therapeutics
$53.30-41.84%
Jonathan Wolleben66%
$21 → $31MaintainsMarket OutperformGet Alert
03/08/2023DBVTBuy Now
DBV Technologies
$5.01-20.16%
Jonathan Wolleben66%
→ $40Reiterates → Market OutperformGet Alert
03/07/2023OCULBuy Now
Ocular Therapeutix
$7.4547.65%
Jonathan Wolleben66%
$12 → $11MaintainsMarket OutperformGet Alert
03/03/2023DBVTBuy Now
DBV Technologies
$5.01-20.16%
Jonathan Wolleben66%
→ $40Reiterates → Market OutperformGet Alert
03/01/2023LRMRBuy Now
Larimar Therapeutics
$2.39527.62%
Jonathan Wolleben66%
→ $15MaintainsMarket OutperformGet Alert
03/01/2023CRNXBuy Now
Crinetics Pharmaceuticals
$34.1819.95%
Jonathan Wolleben66%
$50 → $41MaintainsMarket OutperformGet Alert
02/27/2023PHVSBuy Now
Pharvaris
$15.9644.11%
Jonathan Wolleben66%
→ $23Reiterates → Market OutperformGet Alert
02/22/2023RLYBBuy Now
Rallybio
$0.743817.33%
Jonathan Wolleben66%
→ $29Reiterates → Market OutperformGet Alert
02/22/2023BCRXBuy Now
BioCryst Pharma
$7.55111.92%
Jonathan Wolleben66%
→ $16Reiterates → Market OutperformGet Alert
02/13/2023OCULBuy Now
Ocular Therapeutix
$7.4561.07%
Jonathan Wolleben66%
→ $12Reiterates → Market OutperformGet Alert
02/13/2023CLSDBuy Now
Clearside Biomedical
$0.95636.53%
Jonathan Wolleben66%
→ $7Reiterates → Market OutperformGet Alert
02/06/2023ALTBuy Now
Altimmune
$5.56367.63%
Jonathan Wolleben66%
→ $26Reiterates → Market OutperformGet Alert
01/24/2023LRMRBuy Now
Larimar Therapeutics
$2.39569.46%
Jonathan Wolleben66%
$16 → $16MaintainsMarket OutperformGet Alert
01/11/2023PHVSBuy Now
Pharvaris
$15.9644.11%
Jonathan Wolleben66%
$22 → $23MaintainsMarket OutperformGet Alert
01/09/2023OCULBuy Now
Ocular Therapeutix
$7.4561.07%
Jonathan Wolleben66%
$25 → $12MaintainsMarket OutperformGet Alert
01/08/2023SPRBBuy Now
Spruce Biosciences
$0.322423.66%
Jonathan Wolleben66%
$8 → $8MaintainsOutperformGet Alert
01/05/2023MDGLBuy Now
Madrigal Pharmaceuticals
$340.5014.54%
Jonathan Wolleben66%
$312 → $390MaintainsMarket OutperformGet Alert
12/20/2022MDGLBuy Now
Madrigal Pharmaceuticals
$340.50-8.37%
Jonathan Wolleben66%
$182 → $312MaintainsMarket OutperformGet Alert
12/09/2022PHVSBuy Now
Pharvaris
$15.9637.84%
Jonathan Wolleben66%
$18 → $22MaintainsMarket OutperformGet Alert
11/16/2022SPRBBuy Now
Spruce Biosciences
$0.322423.66%
Jonathan Wolleben66%
→ $8Initiates → Market OutperformGet Alert
11/11/2022AURABuy Now
Aura Biosciences
$7.42304.31%
Jonathan Wolleben66%
$26 → $30MaintainsMarket OutperformGet Alert
11/11/2022ALTBuy Now
Altimmune
$5.56367.63%
Jonathan Wolleben66%
$28 → $26MaintainsMarket OutperformGet Alert
09/19/2022LRMRBuy Now
Larimar Therapeutics
$2.39569.46%
Jonathan Wolleben66%
$10 → $16MaintainsMarket OutperformGet Alert
08/25/2022PTGXBuy Now
Protagonist Therapeutics
$53.30-60.6%
Jonathan Wolleben66%
→ $21Reinstates → Market OutperformGet Alert
08/09/2022RLYBBuy Now
Rallybio
$0.744492.73%
Jonathan Wolleben66%
$29 → $34MaintainsMarket OutperformGet Alert
08/09/2022OCULBuy Now
Ocular Therapeutix
$7.45235.57%
Jonathan Wolleben66%
$20 → $25MaintainsMarket OutperformGet Alert
07/19/2022AURABuy Now
Aura Biosciences
$7.42250.4%
Jonathan Wolleben66%
→ $26Initiates → Market OutperformGet Alert
05/25/2022PHVSBuy Now
Pharvaris
$15.96113.03%
Jonathan Wolleben66%
→ $34Initiates → Market OutperformGet Alert
05/10/2022OCULBuy Now
Ocular Therapeutix
$7.45168.46%
Jonathan Wolleben66%
$22 → $20MaintainsMarket OutperformGet Alert
05/10/2022MDGLBuy Now
Madrigal Pharmaceuticals
$340.50-50.07%
Jonathan Wolleben66%
$200 → $170MaintainsMarket OutperformGet Alert
04/14/2022PRQRBuy Now
ProQR Therapeutics
$1.71192.4%
Jonathan Wolleben66%
$8 → $5MaintainsMarket OutperformGet Alert
03/31/2022CRNXBuy Now
Crinetics Pharmaceuticals
$34.1831.66%
Jonathan Wolleben66%
$43 → $45MaintainsMarket OutperformGet Alert
03/16/2022RLYBBuy Now
Rallybio
$0.743817.33%
Jonathan Wolleben66%
$32 → $29MaintainsMarket OutperformGet Alert
03/11/2022CLSDBuy Now
Clearside Biomedical
$0.95952.19%
Jonathan Wolleben66%
$11 → $10MaintainsMarket OutperformGet Alert
03/01/2022OCULBuy Now
Ocular Therapeutix
$7.45195.3%
Jonathan Wolleben66%
$30 → $22MaintainsMarket OutperformGet Alert
02/22/2022RLYBBuy Now
Rallybio
$0.744222.57%
Jonathan Wolleben66%
→ $32Initiates → Market OutperformGet Alert
02/14/2022PRQRBuy Now
ProQR Therapeutics
$1.71367.84%
Jonathan Wolleben66%
$29 → $8MaintainsMarket OutperformGet Alert
12/21/2021DBVTBuy Now
DBV Technologies
$5.01-0.2%
Jonathan Wolleben66%
$80 → $50MaintainsMarket OutperformGet Alert
11/30/2021CRNXBuy Now
Crinetics Pharmaceuticals
$34.1825.8%
Jonathan Wolleben66%
→ $43Initiates → Market OutperformGet Alert
11/09/2021OCULBuy Now
Ocular Therapeutix
$7.45302.68%
Jonathan Wolleben66%
$27 → $30MaintainsMarket OutperformGet Alert
09/09/2021OCULBuy Now
Ocular Therapeutix
$7.45342.95%
Jonathan Wolleben66%
$30 → $33MaintainsMarket OutperformGet Alert
08/06/2021BCRXBuy Now
BioCryst Pharma
$7.55204.64%
Jonathan Wolleben66%
$22 → $23MaintainsMarket OutperformGet Alert
06/30/2021ALTBuy Now
Altimmune
$5.56457.55%
Jonathan Wolleben66%
$53 → $31MaintainsMarket OutperformGet Alert
06/16/2021ALTBuy Now
Altimmune
$5.56853.24%
Jonathan Wolleben66%
$45 → $53MaintainsMarket OutperformGet Alert
06/15/2021CLSDBuy Now
Clearside Biomedical
$0.95846.97%
Jonathan Wolleben66%
$8 → $9MaintainsMarket OutperformGet Alert
05/25/2021SBBPBuy Now
Strongbridge Biopharma
Jonathan Wolleben66%
DowngradeOutperform → Market PerformGet Alert
07/28/2020ALTBuy Now
Altimmune
$5.56799.28%
Jonathan Wolleben66%
→ $50Initiates → Market OutperformGet Alert
11/13/2019OCULBuy Now
Ocular Therapeutix
$7.45-6.04%
Jonathan Wolleben66%
$9 → $7MaintainsMarket OutperformGet Alert
12/20/2018DBVTBuy Now
DBV Technologies
$5.01299.2%
Jonathan Wolleben66%
$300 → $200Reiterates → Market OutperformGet Alert
05/25/2017CLSDBuy Now
Clearside Biomedical
$0.952109.6%
Jonathan Wolleben66%
→ $21Initiates → Market OutperformGet Alert
01/03/2017MDGLBuy Now
Madrigal Pharmaceuticals
$340.50
Jonathan Wolleben66%
Initiates → OutperformGet Alert
08/11/2016OCULBuy Now
Ocular Therapeutix
$7.45
Jonathan Wolleben66%
Initiates → OutperformGet Alert
03/15/2016PRQRBuy Now
ProQR Therapeutics
$1.71718.71%
Jonathan Wolleben66%
$24 → $14MaintainsMarket OutperformGet Alert
10/14/2014PRQRBuy Now
ProQR Therapeutics
$1.712005.26%
Jonathan Wolleben66%
→ $36Initiates → Market OutperformGet Alert